OrthoPediatrics Corp Quarterly Income Statements Chart
Quarterly
|
Annual
OrthoPediatrics Corp Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net revenue | 61,082,000 | 52,411,000 | 52,667,000 | 54,573,000 | 52,802,000 | 44,685,000 | 37,613,000 | 39,972,000 | 39,559,000 | 31,588,000 | 30,994,000 | 34,950,000 | 32,928,000 | 23,417,000 | 24,813,000 | 25,079,000 | 26,695,000 | 21,462,000 | 18,924,000 | 22,205,000 | 13,593,000 | 16,356,000 | 18,952,000 | 20,744,000 | 18,200,000 | 14,656,000 | 14,568,000 | 15,820,000 | 15,077,000 | 12,094,000 | 11,681,000 | 12,375,000 |
cost of revenue | 17,063,000 | 14,149,000 | 17,102,000 | 14,513,000 | 12,003,000 | 12,511,000 | 10,899,000 | 9,019,000 | 9,534,000 | 8,027,000 | 9,770,000 | 9,061,000 | 7,947,000 | 4,851,000 | 6,732,000 | 6,525,000 | 6,252,000 | 5,137,000 | 3,806,000 | 4,566,000 | 3,532,000 | 4,143,000 | 4,502,000 | 4,849,000 | 4,581,000 | 4,001,000 | 4,054,000 | 3,843,000 | 3,807,000 | 3,175,000 | 2,849,000 | 2,884,000 |
gross profit | 44,019,000 | 38,262,000 | 35,565,000 | 40,060,000 | 40,799,000 | 32,174,000 | 26,714,000 | 30,953,000 | 30,025,000 | 23,561,000 | 21,224,000 | 25,889,000 | 24,981,000 | 18,566,000 | 18,081,000 | 18,554,000 | 20,443,000 | 16,325,000 | 15,118,000 | 17,639,000 | 10,061,000 | 12,213,000 | 14,450,000 | 15,895,000 | 13,619,000 | 10,655,000 | 10,514,000 | 11,977,000 | 11,270,000 | 8,919,000 | 8,832,000 | 9,491,000 |
yoy | 7.89% | 18.92% | 33.13% | 29.42% | 35.88% | 36.56% | 25.87% | 19.56% | 20.19% | 26.90% | 17.38% | 39.53% | 22.20% | 13.73% | 19.60% | 5.19% | 103.19% | 33.67% | 4.62% | 10.97% | -26.13% | 14.62% | 37.44% | 32.71% | 20.84% | 19.46% | 19.04% | 26.19% | ||||
qoq | 15.05% | 7.58% | -11.22% | -1.81% | 26.81% | 20.44% | -13.69% | 3.09% | 27.44% | 11.01% | -18.02% | 3.63% | 34.55% | 2.68% | -2.55% | -9.24% | 25.23% | 7.98% | -14.29% | 75.32% | -17.62% | -15.48% | -9.09% | 16.71% | 27.82% | 1.34% | -12.22% | 6.27% | 26.36% | 0.99% | -6.94% | |
gross margin % | ||||||||||||||||||||||||||||||||
operating expenses: | ||||||||||||||||||||||||||||||||
sales and marketing | 19,103,000 | 16,572,000 | 16,784,000 | 16,750,000 | 16,593,000 | 14,169,000 | 12,439,000 | 13,582,000 | 13,165,000 | 12,216,000 | 10,945,000 | 11,919,000 | 12,431,000 | 9,758,000 | 9,986,000 | 9,862,000 | 10,876,000 | 8,949,000 | 9,433,000 | 9,237,000 | 5,620,000 | 7,564,000 | 8,360,000 | 8,771,000 | 7,606,000 | 6,547,000 | 6,558,000 | 7,150,000 | 6,776,000 | 6,079,000 | 5,405,000 | 5,633,000 |
general and administrative | 30,443,000 | 30,280,000 | 24,431,000 | 26,299,000 | 27,329,000 | 24,730,000 | 19,594,000 | 18,507,000 | 19,654,000 | 17,666,000 | 16,554,000 | 15,116,000 | 14,546,000 | 13,167,000 | 11,898,000 | 11,034,000 | 11,088,000 | 12,041,000 | 10,036,000 | 9,823,000 | 10,577,000 | 7,881,000 | 7,216,000 | 7,267,000 | 6,569,000 | 5,612,000 | 4,545,000 | 4,877,000 | 5,499,000 | 6,017,000 | 6,690,000 | 3,487,000 |
restructuring | 2,971,000 | 40,000 | ||||||||||||||||||||||||||||||
research and development | 2,159,000 | 2,351,000 | 2,916,000 | 2,577,000 | 2,543,000 | 2,998,000 | 2,747,000 | 2,387,000 | 2,792,000 | 2,270,000 | 2,034,000 | 2,206,000 | 1,747,000 | 2,027,000 | 1,608,000 | 1,302,000 | 1,325,000 | 1,308,000 | 2,050,000 | 1,077,000 | 881,000 | 1,265,000 | 1,905,000 | 1,396,000 | 1,234,000 | 1,213,000 | 1,277,000 | 1,122,000 | 1,115,000 | 1,218,000 | 941,000 | 1,127,000 |
total operating expenses | 54,676,000 | 49,243,000 | 49,620,000 | 45,626,000 | 46,465,000 | 41,897,000 | 34,780,000 | 35,461,000 | 35,611,000 | 32,152,000 | 29,533,000 | 32,850,000 | 28,724,000 | 24,952,000 | 23,642,000 | 22,198,000 | 23,289,000 | 22,298,000 | 27,861,000 | 20,137,000 | 17,078,000 | 16,710,000 | 17,481,000 | 17,434,000 | 15,409,000 | 13,372,000 | 12,380,000 | 13,149,000 | 13,390,000 | 13,314,000 | 13,036,000 | 10,247,000 |
operating income | -10,657,000 | -10,981,000 | -14,055,000 | -5,566,000 | -5,666,000 | -9,723,000 | -8,066,000 | -4,508,000 | -5,586,000 | -8,591,000 | -8,309,000 | -6,961,000 | -3,743,000 | -6,386,000 | -5,561,000 | -3,644,000 | -2,846,000 | -5,973,000 | -12,743,000 | -2,498,000 | -7,017,000 | -4,497,000 | -3,031,000 | -1,539,000 | -1,790,000 | -2,717,000 | -1,866,000 | -1,172,000 | -2,120,000 | -4,395,000 | -4,204,000 | -756,000 |
yoy | 88.09% | 12.94% | 74.25% | 23.47% | 1.43% | 13.18% | -2.92% | -35.24% | 49.24% | 34.53% | 49.42% | 91.03% | 31.52% | 6.91% | -56.36% | 45.88% | -59.44% | 32.82% | 320.42% | 62.31% | 292.01% | 65.51% | 62.43% | 31.31% | -15.57% | -38.18% | -55.61% | 55.03% | ||||
qoq | -2.95% | -21.87% | 152.52% | -1.76% | -41.73% | 20.54% | 78.93% | -19.30% | -34.98% | 3.39% | 19.37% | 85.97% | -41.39% | 14.84% | 52.61% | 28.04% | -52.35% | -53.13% | 410.13% | -64.40% | 56.04% | 48.37% | 96.95% | -14.02% | -34.12% | 45.61% | 59.22% | -44.72% | -51.76% | 4.54% | 456.08% | |
operating margin % | ||||||||||||||||||||||||||||||||
other income: | ||||||||||||||||||||||||||||||||
interest expense | 1,116,000 | 1,126,000 | 325,500 | 404,000 | 261,000 | 26,250 | 21,000 | 294,000 | -61,000 | 708,000 | 1,212,000 | 566,000 | 396,000 | 542,000 | 581,000 | 728,000 | 624,000 | 1,010,000 | 1,399,000 | 379,000 | 1,306,000 | 1,297,000 | 632,000 | 303,000 | 533,000 | 608,000 | 562,000 | 552,000 | 633,000 | 761,000 | ||
other income | -4,709,000 | -1,644,000 | 1,035,000 | -63,000 | 120,000 | -24,000 | -331,000 | 128,000 | 945,000 | 827,000 | -105,000 | -281,000 | -267,000 | -375,000 | -160,000 | -332,000 | 122,000 | 121,000 | 69,000 | -8,000 | 41,000 | 37,000 | 69,000 | 85,000 | 10,000 | 53,000 | 8,000 | 20,000 | ||||
total other income | -3,593,000 | -518,000 | 1,141,250 | 3,571,000 | 381,000 | 613,000 | -1,163,000 | -766,000 | ||||||||||||||||||||||||
net income before income taxes | -7,064,000 | -10,463,000 | ||||||||||||||||||||||||||||||
income tax charge | 49,000 | 196,000 | ||||||||||||||||||||||||||||||
net income | -7,113,000 | -10,659,000 | -16,069,000 | -7,919,000 | -6,029,000 | -7,805,000 | -6,691,000 | -4,591,000 | -2,886,000 | -6,806,000 | -7,848,000 | 18,539,000 | -333,000 | -9,100,000 | 72,000 | -2,197,000 | -3,756,000 | -10,379,000 | -14,013,000 | -4,539,000 | -9,447,000 | -4,945,000 | -5,429,000 | -2,664,000 | -2,618,000 | -3,020,000 | -2,468,000 | -1,865,000 | -2,692,000 | -5,000,000 | -4,845,000 | -1,537,000 |
yoy | 17.98% | 36.57% | 140.16% | 72.49% | 108.91% | 14.68% | -14.74% | -124.76% | 766.67% | -25.21% | -11000.00% | -943.83% | -91.13% | -12.32% | -100.51% | -51.60% | -60.24% | 109.89% | 158.11% | 70.38% | 260.85% | 63.74% | 119.98% | 42.84% | -2.75% | -39.60% | -49.06% | 21.34% | ||||
qoq | -33.27% | -33.67% | 102.92% | 31.35% | -22.75% | 16.65% | 45.74% | 59.08% | -57.60% | -13.28% | -142.33% | -5667.27% | -96.34% | -12738.89% | -103.28% | -41.51% | -63.81% | -25.93% | 208.72% | -51.95% | 91.04% | -8.92% | 103.79% | 1.76% | -13.31% | 22.37% | 32.33% | -30.72% | -46.16% | 3.20% | 215.22% | |
net income margin % | ||||||||||||||||||||||||||||||||
weighted-average shares outstanding | ||||||||||||||||||||||||||||||||
basic and diluted | 23,460,144,000 | 23,230,871,000 | 23,171,249,000 | 23,145,064,000 | 22,820,779,000 | |||||||||||||||||||||||||||
net income per share | -0.13 | -0.3 | -0.02 | -0.47 | 0.01 | -0.11 | -0.19 | -0.54 | -0.75 | -0.24 | -0.54 | -0.3 | -0.37 | -0.18 | -0.18 | -0.21 | -0.19 | -0.15 | -0.21 | -0.41 | -1.04 | -1.7 | ||||||||||
basic and diluted | -0.3 | -0.46 | -0.235 | -0.34 | -0.26 | -0.34 | ||||||||||||||||||||||||||
tradename impairment | ||||||||||||||||||||||||||||||||
loss on early extinguishment of debt | 3,230,000 | |||||||||||||||||||||||||||||||
fair value adjustment of contingent consideration | -6,000 | -2,304,000 | -670,000 | -480,000 | -23,010,000 | -5,010,000 | 2,570,000 | -5,510,000 | -1,430,000 | 990,000 | 4,150,000 | 1,701,000 | 909,000 | 910,000 | ||||||||||||||||||
income before income taxes | -6,380,000 | -9,137,000 | -6,047,000 | -10,336,000 | -6,903,000 | -3,742,000 | -3,287,000 | -7,380,000 | -7,896,000 | 14,396,000 | -772,000 | -9,417,000 | -166,000 | -2,489,000 | -4,042,000 | -10,691,000 | ||||||||||||||||
benefit from income taxes | -941,750 | -1,218,000 | -18,000 | -2,531,000 | -212,000 | 849,000 | -401,000 | -574,000 | -48,000 | -4,143,000 | -439,000 | -317,000 | -238,000 | -292,000 | -286,000 | -312,000 | ||||||||||||||||
interest income | 637,000 | -210,000 | ||||||||||||||||||||||||||||||
trademark impairment | 985,000 | 3,609,000 | ||||||||||||||||||||||||||||||
other incomes: | ||||||||||||||||||||||||||||||||
other (income) loss | -351,750 | -787,000 | -289,000 | |||||||||||||||||||||||||||||
weighted-average shares outstanding | ||||||||||||||||||||||||||||||||
basic | 23,077,704,000 | 22,675,477,000 | 22,762,823,000 | 20,704,556,000 | 21,150,219,000 | |||||||||||||||||||||||||||
diluted | 23,077,704,000 | 22,675,477,000 | 22,762,823,000 | 20,947,727,000 | 21,295,323,000 | |||||||||||||||||||||||||||
net income per share | -0.13 | -0.3 | -0.02 | -0.47 | 0.01 | -0.11 | -0.19 | -0.54 | -0.75 | -0.24 | -0.54 | -0.3 | -0.37 | -0.18 | -0.18 | -0.21 | -0.19 | -0.15 | -0.21 | -0.41 | -1.04 | -1.7 | ||||||||||
basic | -0.29 | -0.2 | -0.38 | 0.88 | ||||||||||||||||||||||||||||
diluted | -0.29 | -0.2 | -0.37 | 0.87 | ||||||||||||||||||||||||||||
total other incomes | -2,299,000 | -1,211,000 | -413,000 | -21,357,000 | -2,971,000 | 3,031,000 | -5,395,000 | -1,155,000 | 1,196,000 | 4,718,000 | 1,993,000 | 2,041,000 | 2,430,000 | 448,000 | 1,298,000 | 1,338,000 | 669,000 | 303,000 | 602,000 | 693,000 | 572,000 | 605,000 | 641,000 | 781,000 | ||||||||
weighted-average common stock - basic and diluted | 22,704,723,000 | 22,506,024,000 | 19,792,286,000 | 19,366,911,000 | 19,291,374,000 | 19,275,779,000 | 19,200,231,000 | 19,112,797,000 | 17,549,118,000 | 16,423,853,000 | 14,639,020,000 | 14,451,979,000 | 14,367,056,000 | 12,624,858,000 | 12,549,226,000 | |||||||||||||||||
net income per share | -0.13 | -0.3 | -0.02 | -0.47 | 0.01 | -0.11 | -0.19 | -0.54 | -0.75 | -0.24 | -0.54 | -0.3 | -0.37 | -0.18 | -0.18 | -0.21 | -0.19 | -0.15 | -0.21 | -0.41 | -1.04 | -1.7 | ||||||||||
other incomes | ||||||||||||||||||||||||||||||||
net income from continuing operations | -14,013,000 | -4,539,000 | -9,447,000 | -4,329,000 | -2,877,000 | -2,459,000 | ||||||||||||||||||||||||||
net income from discontinued operations | -159,000 | |||||||||||||||||||||||||||||||
net gain from discontinued operations | 13,500 | 213,000 | ||||||||||||||||||||||||||||||
net income attributable to common stockholders | -5,429,000 | -2,664,000 | -2,618,000 | -2,468,000 | -1,865,000 | -2,692,000 | -5,000,000 | -15,079,000 | -3,021,000 | |||||||||||||||||||||||
weighted-average common shares - basic and diluted | 19,268,255,000 | 18,056,828,000 | 14,624,194,000 | 12,567,387,000 | 12,073,776,000 | 4,017,330,000 | 1,773,385,000 |
We provide you with 20 years income statements for OrthoPediatrics Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OrthoPediatrics Corp stock. Explore the full financial landscape of OrthoPediatrics Corp stock with our expertly curated income statements.
The information provided in this report about OrthoPediatrics Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.